Everest Medicines Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 22, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,483	1,939	776	645	1,164	2,093
Market Cap Growth	-15.39%	149.94%	20.27%	-44.61%	-44.37%	-
Enterprise Value	1,383	1,695	499	445	688	2,377
Last Close Price	4.08	5.65	2.30	1.99	3.58	-
PS Ratio	14.66	20.73	48.28	371.66	155778.93	-
PB Ratio	3.18	3.60	1.22	0.84	1.43	2.44
P/TBV Ratio	7.40	8.06	2.49	1.45	2.46	3.46
EV/Sales Ratio	13.76	18.12	31.04	256.65	92015.48	-
Debt / Equity Ratio	0.19	0.14	0.11	0.10	0.09	0.07
Asset Turnover	-	0.13	0.02	0.00	0	-
Inventory Turnover	-	10.77	2.25	0.77	-	-
Quick Ratio	5.36	2.51	7.55	3.84	9.84	24.04
Current Ratio	5.46	2.54	7.63	3.92	9.95	24.06
Return on Equity (ROE)	-	-23.04%	-15.90%	-4.28%	-15.84%	-189.24%
Return on Assets (ROA)	-	-9.09%	-8.59%	-13.24%	-9.29%	-8.94%
Return on Capital Employed (ROCE)	-15.90%	-18.70%	-15.60%	-24.50%	-16.50%	-9.40%
Earnings Yield	-5.28%	-7.11%	-13.89%	-5.20%	-11.99%	-33.85%
FCF Yield	-3.91%	-5.08%	-14.58%	-31.80%	-9.98%	-2.88%
Buyback Yield / Dilution	-0.25%	-2.51%	-5.18%	-1.49%	-243.61%	-1532.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.